Tesaro, Inc. Details Niraparib Phase 1 Clinical Data Presented at the 2013 American Society of Clinical Oncology Annual Meeting
6/4/2013 9:43:26 AM
More...
|
Tesaro, Inc. to Webcast Investor Briefing at American Society of Clinical Oncology
5/29/2013 10:05:45 AM
More...
|
Tesaro, Inc. to Present at the Deutsche Bank (DB) 38th Annual 2013 Health Care Conference
5/23/2013 10:15:22 AM
More...
|
Tesaro, Inc. Announces Presentation of Niraparib Clinical Data at the 2013 American Society of Clinical Oncology Annual Meeting
5/16/2013 9:08:15 AM
More...
|
Tesaro, Inc. Announces Election of Dr. James Armitage to Board of Directors and Results of Annual Stockholder Meeting
5/9/2013 9:26:28 AM
More...
|
Tesaro, Inc. Nets $91 Million
3/7/2013 8:46:30 AM
More...
|
Tesaro, Inc. Seeks $86.2 Million IPO
3/27/2012 7:48:21 AM
More...
|